Biodegradable Polyamine-Co-Ester Gene Delivery Vectors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current non-viral vectors for gene delivery, such as cationic lipids and polymers, face challenges including instability in physiological fluids, toxicity, and rapid clearance by the reticuloendothelial system due to excess positive charges, limiting their clinical applicability and efficiency for systemic in vivo delivery.
Innovation Solution
Development of biodegradable poly(amine-co-esters) synthesized via enzymatic copolymerization, which form nano-sized polyplexes with DNA and have lower charge densities, enhancing stability and reducing toxicity, allowing for efficient gene delivery with polymers like poly(N-methyldiethyleneamine sebacate) (PMSC), and further modification with ortho ester units to improve biocompatibility and controlled molecular weight.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cationic lipids or polymers are used as non-viral vectors for gene delivery, then transfection efficiency is improved, but toxicity increases and stability in physiological fluids deteriorates
Solution Approach 1:
The patent modifies the chemical structure of cationic polymers by incorporating biodegradable ester linkages and adjusting molecular weight and charge density parameters. This creates poly(amine-co-ester) vectors that maintain transfection efficiency while reducing toxicity through controlled degradation and optimized electrostatic properties.
Solution Approach 2:
The invention creates composite polymeric vectors combining amine groups for DNA binding with biodegradable ester components. This composite structure integrates the benefits of cationic charge for transfection with the biocompatibility and degradability of ester linkages, resolving the toxicity-efficiency contradiction.
2Ease of operation
If cationic polymers with excess positive charges are used to form polyplexes with DNA, then complex formation and cellular uptake are facilitated, but rapid clearance by the reticuloendothelial system occurs
Solution Approach 1:
The patent optimizes the charge density parameter of the cationic polymer by balancing amine content with biodegradable ester components. This creates polyplexes with sufficient positive charge for cellular uptake but reduced net charge to minimize reticuloendothelial system recognition and clearance, extending circulation half-life.
Solution Approach 2:
The biodegradable ester linkages enable controlled degradation of the polymer in circulation, continuously releasing the cationic amine groups that facilitate cellular uptake while the degrading polymer chain avoids accumulation and rapid clearance by the reticuloendothelial system.
3Reliability
If cationic vectors are used for gene delivery, then DNA condensation and protection are achieved, but instability in physiological fluids occurs
Solution Approach 1:
The biodegradable ester linkages provide continuous DNA protection through stable polyplex formation in circulation, while simultaneously enabling controlled degradation in physiological fluids to release the DNA at the target site, resolving the contradiction between protection and stability.
Solution Approach 2:
The patent adjusts the molecular weight and composition parameters of the cationic polymer to create polyplexes that are stable enough for circulation but susceptible to enzymatic degradation by esterases in physiological fluids, achieving both DNA protection and controlled release.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymers demonstrate significantly higher transfection efficiency and reduced toxicity compared to commercial vectors like Lipofectamine 2000 and PEI, enabling effective systemic delivery of nucleic acids with improved stability and biocompatibility, suitable for both in vitro and in vivo applications.
Implementation Method 1
Both cationic lipid and cationic polymer systems deliver genes by forming condensed complexes with negatively charged DNA through electrostatic interactions
Implementation Method 2
Development of biodegradable poly(amine-co-esters) synthesized via enzymatic copolymerization, which form nano-sized polyplexes with DNA
Data Source
AI summary
Polyamine-co-ester-co-ortho ester) polymers, methods of forming active agent-load nanoparticles therefrom, and methods of using the nanoparticles for drug delivery are disclosed. The nanoparticles can be coated with an agent that reduces surface charge, an agent that increases cell-specific targeting, or a combination thereof. Typically, the loaded nanoparticles are less toxic, more efficient at drug delivery, or a combination thereof compared to a control or other transfection reagents.